Work

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS

Year: 2016

Type: article

Abstract: The paper provides guidelines for the use of tumor necrosis factor-α (TNF-α) inhibitors in the treatment of patients with axial spondyloarthritis (axSpA), including ankylosing spondylitis. It gives data on the efficacy of TNF-α inhibitors in patients with non-radiographic axSpA. By using international and Russian guidelines, the authors lay down indications for this therapy and criteria for evaluation of its efficiency and safety.

Source: Rheumatology Science and Practice

DOI: 10.14412/1995-4484-2016-1s-75-79

Authors: S. A. Lapshina, T. V. Dubinina, V. V. Badokin, A. G. Bochkova, O. V. Bugrova, I. Z. Gaidukova, A. A. Godzenko, A. A. Dubikov, O. N. Ivanova, T. V. Korotaeva, O. B. Nesmeyanova, I. P. Nikishina, E. N. Otteva, T. A. Raskina, A. P. Rebrov, O. A. Rumyantseva, A. V. Sitalo, A. V. Smirnov, Sh. F. Erdes

Institutions: Kazan State Medical University, Association of Rheumatologists of Russia, Ministry of Health of the Russian Federation, Orenburg State Medical Academy, Saratov State Medical University, Vladivostok State Medical University, Kemerovo State Medical University

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W2540282956

FWCI: 0.684

Cites:

Cited by: 10

Related to: 10